Extrahepatic manifestations of HCV.
The hepatic consequences of an infection with the hepatitis C virus (HCV) are well recognised, but extrahepatic manifestations of HCV may be just as severe. Here we have reviewed various extrahepatic manifestations of HCV such as mixed cryoglobulinemia, lymphoma, metabolic features and neurologic consequences and we discuss pathogenesis and management of these clinical problems. We concluded with important aspects of therapy with novel anti-HCV agents and its effects on extrahepatic manifestations.
Division of Gastroenterology and Hepatology Geneva University Hospital, Geneva, Switzerland - rocco.grignoli@hcuge.ch.
R
R
Grignoli
N
N
Goossens
F
F
Negro
D000998:Antiviral Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000821:virology; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000821:virology*; D060825:Cognitive Dysfunction / Q000821:virology; D003449:Cryoglobulinemia / Q000821:virology*; D003924:Diabetes Mellitus, Type 2 / Q000821:virology*; D019317:Evidence-Based Medicine; D016174:Hepacivirus / Q000187:drug effects / Q000472:pathogenicity*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007333:Insulin Resistance; D008223:Lymphoma / Q000821:virology*; D024821:Metabolic Syndrome / Q000821:virology*; D016896:Treatment Outcome; D014779:Virus Replication
D000998:Antiviral Agents